Advances in Experimental Medicine and Biology

Journal

Publication Venue For

  • Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure.  1161:45-64. 2019
  • Cardiac rehabilitation for women.  1065:565-577. 2018
  • Optimizing ERG measures of scotopic and photopic critical flicker frequency.  1074:145-150. 2018
  • Preservation of quiescent chronic myelogenous leukemia stem cells by the bone marrow microenvironment.  1100:97-110. 2018
  • Recent progress in vascular tissue-engineered blood vessels.  1064:123-144. 2018
  • Role of prostate MRI in the setting of active surveillance for prostate cancer.  1126:49-67. 2018
  • X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity..  1049:103-133. 2018
  • High-density lipoprotein regulation of mitochondrial function.  982:407-429. 2017
  • Small angle scattering for pharmaceutical applications: From drugs to drug delivery systems.  1009:239-262. 2017
  • Taurine supplementation reduces renal nerve activity in male rats in which renal nerve activity was increased by a high sugar diet.  975:27-37. 2017
  • Approaches to inactivate genes in zebrafish.  916:61-86. 2016
  • Perinatal taurine exposure alters hematological and chemical properties of blood in adult male rats.  803:157-166. 2015
  • Taurine supplementation prevents the adverse effect of high sugar intake on arterial pressure control after cardiac ischemia/reperfusion in female rats.  803:597-611. 2015
  • The effect of perinatal Taurine on adult renal function does not appear to be mediated by Taurine’s inhibition of the renin-angiotensin system.  803:665-677. 2015
  • A20 expressing tumors and anticancer drug resistance.  809:65-81. 2014
  • CEP290 and the primary cilium.  801:519-525. 2014
  • Modulation of the rate of retinal degeneration in T17M RHO mice by reprogramming the unfolded protein response..  801:455-462. 2014
  • High sugar intake blunts arterial baroreflex via estrogen receptors in perinatal taurine supplemented rats.  775:437-448. 2013
  • Perinatal taurine exposure programs patterns of autonomic nerve activity responses to tooth pulp stimulation in adult male rats.  775:121-134. 2013
  • Perinatal taurine imbalance alters the interplay of renin-angiotensin system and estrogen on glucose-insulin regulation in adult female rats.  776:67-80. 2013
  • Sodium fluxes and astroglial function..  961:295-305. 2013
  • Cellular immunity in breast milk: Implications for postnatal transmission of HIV-1 to the infant.  743:161-169. 2012
  • Building the machines: Scaffolding protein functions during bacteriophage morphogenesis.  726:325-350. 2012
  • ERG critical flicker frequency assessment in humans.  723:503-509. 2012
  • Functional rescue of P23H rhodopsin photoreceptors by gene delivery.  723:191-197. 2012
  • Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant..  743:161-169. 2012
  • Neonatal herpes simplex virus infections: Where are we now?.  697:221-230. 2011
  • What's new in diagnostic testing and treatment approaches for mycoplasma pneumoniae infections in children?.  719:47-57. 2011
  • Enhancing medical research efficiency by using concept maps.  696:581-588. 2011
  • 1 rhodopsin mutations in congenital night blindness.  664:263-272. 2010
  • ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.  660:1-4. 2010
  • Role of menin in neuroendocrine tumorigenesis.  668:87-95. 2009
  • Therapy of herpes virus infections in children.  609:216-232. 2008
  • Classification of ovarian cancer: a genomic analysis..  622:23-33. 2008
  • Classification of ovarian cancer: A genomic analysis.  622:23-33. 2008
  • Fc receptor-like proteins (FCRL): immunomodulators of B cell function..  596:155-162. 2007
  • CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses..  590:171-183. 2007
  • The function of local lymphoid tissues in pulmonary immune responses..  590:55-68. 2007
  • CD38: An ecto-enzyme at the crossroads of innate and adaptive immune responses.  590:171-183. 2007
  • Fc receptor-like proteins (FCRL): Immunomodulators of B cell function.  596:155-162. 2007
  • The function of local lymphoid tissues in pulmonary immune responses.  590:55-68. 2007
  • Alterations of T lymphocytes in inflammatory bowel diseases.  579:133-148. 2006
  • Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease.  579:117-132. 2006
  • Acquisition and use of digital images for pathology education and practice.  563:178-193. 2005
  • Effective communication of antimicrobial susceptibility data by pathologists to clinicians.  563:165-177. 2005
  • Selected case studies in hematopathology: Application of current ancillary techniques in diagnosis.  563:112-124. 2005
  • Surgical pathology of the parathyroid glands.  563:1-9. 2005
  • Uncommon and relatively uncommon lesions of the female reproductive system.  563:10-20. 2005
  • Congenital cytomegalovirus infection: Epidemiology and treatment.  549:155-160. 2004
  • A hypothesis for the etiology of interstitial cystitis.  539 B:683-712. 2004
  • Association of clinical diagnostic tests and dry eye surveys: The NEI-VFQ-25 and the OSDI©.  506 B:1177-1181. 2002
  • Patient-reported versus doctor-diagnosed dry eye: The assessment of symptoms.  506 B:1189-1193. 2002
  • The repeatability of diagnostic tests and surveys in dry eye.  506 B:1171-1175. 2002
  • The thickness of the post-lens tear film measured by interferometry.  506 B:929-933. 2002
  • Regulation of spleen white pulp structure and function by lymphotoxin.  512:49-56. 2002
  • Results of a dry eye questionnaire from optometric practices in North America.  506 B:1009-1016. 2002
  • The role of human milk in necrotizing enterocolitis.  503:83-90. 2002
  • Homeostasis of the mucosal immune system: Human milk and lactation.  501:197-205. 2001
  • Presence of carotenoid, an anticarcinogenic marker, in nipple aspirates postlactation.  501:143-152. 2001
  • Therapeutic approaches to the management of herpes zoster.  458:159-165. 1999
  • The size of corneal epithelial cells collected by contact lens cytology from dry eyes.  438:831-834. 1998
  • Novel non-peptidic opioid compounds with immunopotentiating effects.  437:183-187. 1998
  • Fatty acids and breast cancer cell proliferation.  422:57-69. 1997
  • In defense of mucosal surfaces: Regulation and manipulation of the mucosal immune system.  412:373-385. 1997
  • Clinical experience with non-nucleoside reverse transcreptase inhibitors: L-697,661 and nevirapine.  394:291-298. 1996
  • Autoimmunity due to defective Nur77, Fas, and TNF-RI apoptosis.  406:241-262. 1996
  • Sorivudine: A potent inhibitor of varicella zoster virus replication.  394:41-44. 1996
  • Analysis of intestinal intraepithelial lymphocyte (IEL) T cells in mice expressing anti-CD8 immunoglobulin transgenes.  371:125-128. 1995
  • Compartmentalization within the common mucosal immune system.  371:97-101. 1995
  • Autoimmunity, apoptosis defects and retroviruses.  374:183-201. 1995
  • Characterization of IgA1, IgA2 and secretory IgA carbohydrate chains using plant lectins.  371:585-589. 1995
  • Clonal antibody dominance after influenza vaccination in IgA nephropathy patients and controls.  371:829-834. 1995
  • Decreased IgA-producing cells in the gut of SIV-infected rhesus monkeys.  371:1035-1038. 1995
  • Dendritic cells regulate development of alloantigenic and mitogenic T(H)1 versus T(H)2 responses.  378:347-349. 1995
  • Do CD5 B cells respond to oral antigens?.  371:1439-1444. 1995
  • Ig-Secreting and interferon-γ-producing cells in mice mucosally immunized with influenza virus.  371:1587-1590. 1995
  • IgA nephropathy: A disease of incomplete IgA 1 glycosylation?.  376:221-222. 1995
  • IgA production and transport in the murine liver after mucosal immunization.  371:1061-1066. 1995
  • Induction of salivary IgA responses to Streptococcus mutans antigen I/II after intranasal immunization.  371:1153-1156. 1995
  • Intraperitoneal administration of tetanus toxoid elicits a specific responses of antibody-secreting cells in the peritoneal cavity.  371:103-106. 1995
  • Oral immunization studies with streptococcus mutans and influenza vaccines in rhesus macaque monkeys.  371:1423-1429. 1995
  • Oral tolerance in humans: T cell but not B cell tolerance to a soluble protein antigen.  371:1225-1228. 1995
  • Phylogeny of the immunoglobulin joining (J) chain.  371:353-356. 1995
  • Potential role of dietary isoflavones in the prevention of cancer.  354:135-147. 1994
  • Divergent T-cell cytokine profiles induced by dendritic cells from different tissues.  329:47-53. 1993
  • Cytokine production and T cell receptor expression by salivary gland T cells and intraepithelial T lymphocytes for the regulation of the IgA response.  327:119-131. 1992
  • Induction of T helper cells and cytokines for mucosal IgA responses.  327:107-117. 1992
  • Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses.  327:191-198. 1992
  • Prospects for human mucosal vaccines.  327:13-21. 1992
  • Legionella pneumophilia infection and cytokine production.  319. 1992
  • Acyclovir: The past ten years.  278:243-253. 1990
  • Preface.  278. 1990
  • Cigarette smoking and extracranial carotid atherosclerosis..  273:39-49. 1990
  • Immunologically-mediated pituitary-adrenal activation..  245:217-223. 1988
  • Regulation of EGF receptor and transforming growth factor-alpha expression..  234:105-126. 1988
  • Role of the galt contrasuppressor T cell circuit in isotype-specific immunoregulation..  237:649-653. 1988
  • A peptide binding protein which plays a role in antigen presentation..  225:161-164. 1987
  • Altered patterns of secretion of IgA and IgG subclasses by ulcerative colitis and Crohn's disease intestinal mononuclear cells..  216 A:335-344. 1987
  • Antibodies directed at Fab of IgA in the sera of normal individuals and IgA nephropathy patients..  216 B:1537-1544. 1987
  • Binding, uptake and processing of various molecular forms of IgA by human hepatoma cell line (HepG2)..  216 B:1117-1123. 1987
  • Characterization of liposomes for oral vaccines..  216 B:1771-1780. 1987
  • Complement phenotypes (C3 and C4) in IgA nephropathy..  216 B:1569-1575. 1987
  • Coupling of B cell surface Ig, Ia and BSF1 receptors to intracellular "second messengers"..  213:195-205. 1987
  • Current correction factors inadequately predict the relationship between transcutaneous (tc) and arterial PCO2 in sick neonates..  220:51-53. 1987
  • Detection of food antigen-specific IgA immune complexes in human sera..  216 A:813-820. 1987
  • Differential expression of IgA- and IgM-rheumatoid factors in human disease: evidence for independent regulation of rheumatoid factor isotype production..  216 B:1627-1639. 1987
  • Glycoconjugate receptors for bacteria attaching to mucosal sites: examples for Escherichia coli and Streptococcus pneumoniae..  216 B:931-939. 1987
  • IgA on the surface of erythrocytes from IgA nephropathy patients..  216 B:1577-1581. 1987
  • IgA subclass responses to lipopolysaccharide in humans..  216 B:1199-1205. 1987
  • Immunohistochemical study of the ontogeny of the secretory immune system..  216 B:1359-1368. 1987
  • Immunological studies of IgA nephropathy: familial and racial aspects..  216 B:1489-1498. 1987
  • Induction of secretory immunity to type 3 Streptococcus pneumoniae by oral immunization..  216 B:1765-1770. 1987
  • Influence of IgA on carbohydrate-mediated clearance of antigen..  216 B:1125-1131. 1987
  • Inhibition of natural killer (NK) activity by human colostral and serum IgA..  216 A:539-542. 1987
  • Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines..  216 B:1691-1700. 1987
  • Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses..  216 B:1741-1747. 1987
  • Oral immunization with bacterial antigen induces IgA-secreting cells in peripheral blood in humans..  216 B:1709-1719. 1987
  • Pathogenesis and significance of urogenital mycoplasmal infections..  224:93-115. 1987
  • Regulatory T cell networks in the secretory immune system..  216 A:45-55. 1987
  • Secretory component binding: immunofluorescence and ultrastructural studies..  216 B:1085-1094. 1987
  • Trinitrophenyl reactive T-cell clones in functional and molecular analysis of the HLA-D region..  225:43-54. 1987
  • Type-specific antibodies against group B streptococci in human serum, saliva and vaginal secretions..  216 B:995-1003. 1987
  • Herpesvirus infections in the immunocompromised host: diagnosis and management..  202:95-118. 1986
  • Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus..  189:176-205. 1985
  • Vascular basement membranes: preparation and properties of material isolated with the use of detergents..  131:89-103. 1980
  • Concept of the local and common mucosal immune response..  107:185-192. 1978
  • Effective immunity to dental caries: selective induction of secretory immunity by oral administration of Streptococcus mutans in rodents..  107:261-269. 1978
  • Generation of clonal and isotype diversity..  107:9-17. 1978
  • Induction of secretory antibodies in humans following ingestion of Streptococcus mutans..  107:177-184. 1978
  • L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT): A probe for regulatory mechanisms in antibody responses..  98:419-428. 1978
  • Molecular-cellular interactions in the secretory IgA system..  107:209-217. 1978
  • Report of the summation committee: recommended areas for future research..  107:883-888. 1978
  • Secretory immunity and immunodeficiency..  107:401-410. 1978
  • Use of mutants in the elucidation of virulence of Streptococcus mutans..  107:673-683. 1978
  • Association of S-IgA subunits..  45:99-109. 1974
  • The carbohydrate composition of glycopeptides isolated from IgA2 immunoglobulin..  45:219-222. 1974
  • The origin of monomeric and polymeric forms of IgA in man..  45:57-65. 1974
  • Immunological and clinical effects of transfer factor in anergic subjects..  29:343-350. 1973
  • International Standard Serial Number (issn)

  • 0065-2598
  • Electronic International Standard Serial Number (eissn)

  • 2214-8019